<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Oral COVID-19 Vaccine Candidate Cleared by FDA
Image Overlay - Oral COVID-19 Vaccine Candidate Cleared by FDA

Oral COVID-19 Vaccine Candidate Cleared by FDA

Oral COVID-19 Vaccine Candidate Cleared by FDA

Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, announced that the U.S. Food and Drug Administration (FDA) had completed its review of the Company’s Investigational New Drug (IND) application for its Phase 1 clinical trial evaluating its oral COVID-19 vaccine candidate. No matter the dosage form, Yourway is prepared to support clinical trials from start to finish.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Precision in Pharma Supply Chain Summit Boston

November 16-17, 2026
Boston, MA

SCOPE Supply Chain & Logistics Leadership Summit

March 1-4, 2027
Orlando, FL

Media

Articles

Promises Start Partnerships. Performance Builds Them.

Open chat
Come chat with us!
Hello! How can I help you?